📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The Differential Metabolic Signature of Breast Cancer Cellular Response to Olaparib Treatment. (2022)

First Author: Berardi D

Attributed to: Multiscale Metrology Suite for Next-Generation Health Nanotechnologies funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/cancers14153661

PubMed Identifier: 35954325

Publication URI: http://europepmc.org/abstract/MED/35954325

Type: Journal Article/Review

Volume: 14

Parent Publication: Cancers

Issue: 15

ISSN: 2072-6694